BLB&B Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,413
Closed -$206K 261
2021
Q1
$206K Sell
2,413
-1,883
-44% -$169K 0.02% 242
2020
Q4
$406K Buy
4,296
+75
+2% +$6.55K 0.03% 195
2020
Q3
$367K Sell
4,221
-260
-6% -$22.5K 0.04% 184
2020
Q2
$391K Sell
4,481
-405
-8% -$35K 0.04% 182
2020
Q1
$403K Sell
4,886
-980
-17% -$87.4K 0.05% 172
2019
Q4
$555K Buy
5,866
+30
+0.5% +$2.69K 0.06% 176
2019
Q3
$507K Sell
5,836
-54
-0.9% -$4.85K 0.06% 183
2019
Q2
$538K Buy
5,890
+991
+20% +$83.9K 0.06% 182
2019
Q1
$422K Sell
4,899
-360
-7% -$28.9K 0.05% 192
2018
Q4
$404K Sell
5,259
-846
-14% -$65.9K 0.06% 187
2018
Q3
$471K Sell
6,105
-558
-8% -$41.3K 0.06% 194
2018
Q2
$451K Sell
6,663
-368
-5% -$25.4K 0.06% 197
2018
Q1
$509K Hold
7,031
0.07% 182
2017
Q4
$529K Sell
7,031
-363
-5% -$27.4K 0.08% 179
2017
Q3
$569K Buy
7,394
+1,507
+26% +$114K 0.09% 173
2017
Q2
$440K Sell
5,887
-123
-2% -$8.72K 0.07% 190
2017
Q1
$400K Buy
6,010
+2,645
+79% +$176K 0.07% 194
2016
Q4
$220K Sell
3,365
-725
-18% -$47K 0.04% 265
2016
Q3
$289K Sell
4,090
-223
-5% -$16.3K 0.05% 220
2016
Q2
$319K Sell
4,313
-72
-2% -$4.97K 0.06% 211
2016
Q1
$285K Sell
4,385
-219
-5% -$14.9K 0.06% 212
2015
Q4
$355K Sell
4,604
-159
-3% -$12.6K 0.08% 189
2015
Q3
$392K Hold
4,763
0.09% 178
2015
Q2
$420K Sell
4,763
-558
-10% -$51.2K 0.09% 176
2015
Q1
$470K Sell
5,321
-558
-9% -$49.5K 0.1% 162
2014
Q4
$488K Sell
5,879
-399
-6% -$33.1K 0.1% 162
2014
Q3
$529K Sell
6,278
-825
-12% -$66.7K 0.11% 158
2014
Q2
$576K Sell
7,103
-67
-0.9% -$5.27K 0.12% 155
2014
Q1
$546K Buy
7,170
+240
+3% +$17.5K 0.12% 160
2013
Q4
$499K Buy
6,930
+792
+13% +$55.1K 0.12% 153
2013
Q3
$422K Sell
6,138
-40
-0.6% -$2.65K 0.11% 160
2013
Q2
$391K Buy
+6,178
New +$402K 0.11% 162

Other funds holding NVS